Difference between revisions of "rotation:molecualr-april2020week2"

From MGH Learn Pathology
(Created page with "<table class='table border1px' align="center"> <tr> <th width="10%">Time</th> <th width="18%">Monday 4/6</th> <th width="18%">Tuesday 4/7</th> <th width="18%">Wednesday 4/8</t...")
 
 
(11 intermediate revisions by the same user not shown)
Line 2: Line 2:
 
<tr>
 
<tr>
 
<th width="10%">Time</th>
 
<th width="10%">Time</th>
−
<th width="18%">Monday 4/6</th>
+
<th width="18%">Monday 4/13</th>
−
<th width="18%">Tuesday 4/7</th>
+
<th width="18%">Tuesday 4/14</th>
−
<th width="18%">Wednesday 4/8</th>
+
<th width="18%">Wednesday 4/15</th>
−
<th width="18%">Thursday 4/9</th>
+
<th width="18%">Thursday 4/16</th>
−
<th width="18%">Friday 4/10</th>
+
<th width="18%">Friday 4/17</th>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
Line 12: Line 12:
 
<td> </td>
 
<td> </td>
 
<td> </td>
 
<td> </td>
−
<td> </td>
+
<td bgcolor="#7DE3A0" rowspan="3">
−
<td> </td>
+
Alex Farahani
 +
<br>Metabase
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 +
</td>
 +
<td bgcolor="#7DE3A0" rowspan="3">
 +
Alex Farahani
 +
<br>Metabase
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 +
</td>
 
<td> </td>
 
<td> </td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>8:30–9:00</th>
 
<th>8:30–9:00</th>
−
<td bgcolor="#76C9F0" rowspan="2">
 
−
CID Consensus
 
−
<br/>Zoom
 
−
</td>
 
 
<td> </td>  
 
<td> </td>  
−
<td> </td>
+
<td> </td>  
−
<td> </td>
 
 
<td bgcolor="#7DE3A0" rowspan="5">
 
<td bgcolor="#7DE3A0" rowspan="5">
 
Long P. Le, M.D., Ph.D.
 
Long P. Le, M.D., Ph.D.
Line 34: Line 37:
 
<tr>
 
<tr>
 
<th>9:00–9:30</th>
 
<th>9:00–9:30</th>
−
<td bgcolor="#7DE3A0" rowspan="2">
+
<td> </td>
−
Jochen K. Lennerz, M.D., Ph.D.
+
<td> </td>
−
<br>Ensemble
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#76C9F0" rowspan="2">
 
−
Team Project Meeting<br>Zoom
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Lauren Ritterhouse, M.D., Ph.D.
 
−
<br>NGS Sequencing Technologies
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>9:30–10:00</th>
 
<th>9:30–10:00</th>
−
<td bgcolor="#76C9F0" >
+
<td bgcolor="#7DE3A0" rowspan="3">
−
Jochen K. Lennerz, M.D., Ph.D.
 
−
<br>Introduction to CID
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
</tr>
 
−
<tr>
 
−
<th>10:00–10:30</th>
 
−
<td bgcolor="#76C9F0" rowspan="2">
 
 
Valentina Nardi, M.D.
 
Valentina Nardi, M.D.
−
<br>Overview/Media Lab/SOPs
+
<br>aCGH Case Review
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
−
<td bgcolor="#7DE3A0" rowspan="3">
+
<td> </td>
−
Valentina Nardi, M.D.
 
−
<br>FISH
 
−
<br>Small Molecular Technologies and Techniques
 
−
</td>
 
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
 
Dora Dias-Santagata, Ph.D.
 
Dora Dias-Santagata, Ph.D.
−
<br>Chimerism
+
<br>Thyroid Tumors
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
−
Jochen K. Lennerz, M.D., Ph.D.
+
Adam Fisch, M.D., Ph.D.
−
<br>Billing and Reimbursement
+
<br>Fusion Case Review
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
−
<th>10:30–11:00</th>
+
<th>10:00–10:30</th>
 +
<td bgcolor="#7DE3A0" rowspan="2">
 +
John Iafrate, M.D., Ph.D.
 +
<br>Liquid Biopsies
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 +
</td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
−
<th>11:00–11:30</th>
+
<th>10:30–11:00</th>
−
<td bgcolor="#FFB872" >
+
<td> </td>
 +
<td bgcolor="#7DE3A0" rowspan="3">
 
Jochen K. Lennerz, M.D., Ph.D.
 
Jochen K. Lennerz, M.D., Ph.D.
−
<br>Expectations
+
<br>FISH Case Review
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Dora Dias-Santagata, Ph.D.
 
−
<br>aCGH Technique, Cytovision, and Analysis
 
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 +
</tr>
 +
<tr>
 +
<th>11:00–11:30</th>
 +
<td> </td>
 +
<td> </td>
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
 
Lauren Ritterhouse, M.D., Ph.D.
 
Lauren Ritterhouse, M.D., Ph.D.
−
<br>Tumor Mutational Burden
+
<br>Molecular Oncology of GYN Tumors
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Valentina Nardi, M.D.
 
−
<br>Interpretation of Gene Fusions
 
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 +
<td> </td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>11:30–12:00</th>
 
<th>11:30–12:00</th>
−
<td bgcolor="#FFB872" >
+
<td> </td>
−
Adam Fisch, M.D., Ph.D.
+
<td> </td>
−
<br>Pre-Rotation Testing
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
 
<td> </td>
 
<td> </td>
 
</tr>
 
</tr>
Line 140: Line 119:
 
<th>1:00–1:30</th>
 
<th>1:00–1:30</th>
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
−
Jochen K. Lennerz, M.D., Ph.D.
+
Nick Jessop
−
<br>Financial Sustainability
+
<br>Case Management
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 
<td rowspan="2">
 
<td rowspan="2">
 
LMM Conference
 
LMM Conference
−
<br>MS Teams CP Residents
+
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3addc83935c1ba4881bf3c214441deec8a%40thread.skype/CP%2520residents?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams CP Residents</htmltag>
 +
</td>
 +
<td bgcolor="#7DE3A0" rowspan="4">
 +
Valentina Nardi, M.D.
 +
<br>Small Molecular/NGS Case Review
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 +
</td>
 +
<td bgcolor="#7DE3A0" rowspan="4">
 +
Adam Fisch, M.D., Ph.D.
 +
<br>SNV/Indel Case Review
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
−
<td> </td>
 
−
<td> </td>
 
 
<td> </td>
 
<td> </td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>1:30–2:00</th>
 
<th>1:30–2:00</th>
−
<td> </td>
 
−
<td> </td>
 
 
<td> </td>
 
<td> </td>
 
</tr>
 
</tr>
Line 161: Line 146:
 
<th>2:00–2:30</th>
 
<th>2:00–2:30</th>
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
−
Valentina Nardi, M.D.
+
Ryan Frazier
−
<br>Nomenclature
+
<br>Digital Pathology
 
<br>
 
<br>
 
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
Line 169: Line 154:
 
Heme Molecular Conference
 
Heme Molecular Conference
 
<br>TBD
 
<br>TBD
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Julia Thierauf, M.D.
 
−
<br>Clinical Research
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
−
</td>
 
−
<td bgcolor="#7DE3A0" rowspan="2">
 
−
Lauren Ritterhouse, M.D., Ph.D.
 
−
<br>Pre-Analytic Factors Affecting  Molecular Testing
 
−
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
 
</td>
 
</td>
 
<td bgcolor="#7DE3A0" rowspan="6">
 
<td bgcolor="#7DE3A0" rowspan="6">
Line 194: Line 169:
 
<tr>
 
<tr>
 
<th>3:00–3:30</th>
 
<th>3:00–3:30</th>
−
<td> </td>
 
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
−
Maristela Onozato, M.D., Ph.D.
+
Valentina Nardi, M.D.
−
<br>Research
+
<br>AML Testing in Era of Targeted Therapies
 +
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 +
</td>
 +
<td bgcolor="#7DE3A0" rowspan="4">
 +
Jochen K. Lennerz, M.D., Ph.D.
 +
<br>FISH Case Review
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
−
Ju Cheng Ph.D.
+
Hetal Marble, Ph.D.
−
<br>Translational Research
+
<br>Clinical Trials
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
−
Hetal Marble, Ph.D.
+
Valentina Nardi, M.D.
−
<br>CID Core Concept
+
<br>Case Review
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
Line 213: Line 192:
 
<tr>
 
<tr>
 
<th>3:30–4:00</th>
 
<th>3:30–4:00</th>
−
<td> </td>
 
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>4:00–4:30</th>
 
<th>4:00–4:30</th>
−
<td> </td>
 
−
<td> </td>
 
 
<td> </td>
 
<td> </td>
 
<td bgcolor="#7DE3A0" rowspan="2">
 
<td bgcolor="#7DE3A0" rowspan="2">
−
Hetal Marble, Ph.D.
+
John Iafrate, M.D., Ph.D.
−
<br>Companion Diagnostics
+
<br>Lung Cancer Update
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
<br><htmltag tagname="a" href="https://teams.microsoft.com/l/channel/19%3a501d8afad489456ca33e8a95303a864c%40thread.skype/Molecular?groupId=6b1fef6a-ba74-472a-bcf5-b97902959154&tenantId=720edb1f-5c4e-4043-8141-214a63a7ead5" target="_blank">MS Teams Molecular</htmltag>
 
</td>
 
</td>
 +
<td> </td>
 
</tr>
 
</tr>
 
<tr>
 
<tr>
 
<th>4:30–5:00</th>
 
<th>4:30–5:00</th>
−
<td> </td>
 
 
<td> </td>
 
<td> </td>
 
<td> </td>
 
<td> </td>
 
</tr>
 
</tr>
 
</table>
 
</table>
−
{{ColorText|Molecular residents and HMS students|#76C9F0|3}}<br>
+
{{ColorText|All: residents, fellows, HMS students|#7DE3A0|3}}
−
{{ColorText|All: residents, fellows, HMS students|#7DE3A0|3}}<br>
 
−
{{ColorText|Molecular residents only|#FFB872|3}}
 

Latest revision as of 10:28, April 11, 2020

Time Monday 4/13 Tuesday 4/14 Wednesday 4/15 Thursday 4/16 Friday 4/17
8:00–8:30

Alex Farahani
Metabase
MS Teams Molecular

Alex Farahani
Metabase
MS Teams Molecular

8:30–9:00

Long P. Le, M.D., Ph.D.
Markus Herrmann, M.D., Ph.D.
Computational Pathology
MS Teams Molecular

9:00–9:30
9:30–10:00

Valentina Nardi, M.D.
aCGH Case Review
MS Teams Molecular

Dora Dias-Santagata, Ph.D.
Thyroid Tumors
MS Teams Molecular

Adam Fisch, M.D., Ph.D.
Fusion Case Review
MS Teams Molecular

10:00–10:30

John Iafrate, M.D., Ph.D.
Liquid Biopsies
MS Teams Molecular

10:30–11:00

Jochen K. Lennerz, M.D., Ph.D.
FISH Case Review
MS Teams Molecular

11:00–11:30

Lauren Ritterhouse, M.D., Ph.D.
Molecular Oncology of GYN Tumors
MS Teams Molecular

11:30–12:00
12:00–1:00 OUTS Conference

MS Teams OUTS

OUTS Conference

MS Teams OUTS

OUTS Conference

MS Teams OUTS

AP Lecture Series

MS Teams AP Residents

OUTS Conference

MS Teams OUTS

1:00–1:30

Nick Jessop
Case Management
MS Teams Molecular

LMM Conference
MS Teams CP Residents

Valentina Nardi, M.D.
Small Molecular/NGS Case Review
MS Teams Molecular

Adam Fisch, M.D., Ph.D.
SNV/Indel Case Review
MS Teams Molecular

1:30–2:00
2:00–2:30

Ryan Frazier
Digital Pathology
MS Teams Molecular

Heme Molecular Conference
TBD


Long P. Le, M.D., Ph.D.
Markus Herrmann, M.D., Ph.D.
Computational Pathology
MS Teams Molecular
OR
Research Talks

2:30–3:00
3:00–3:30

Valentina Nardi, M.D.
AML Testing in Era of Targeted Therapies
MS Teams Molecular

Jochen K. Lennerz, M.D., Ph.D.
FISH Case Review
MS Teams Molecular

Hetal Marble, Ph.D.
Clinical Trials
MS Teams Molecular

Valentina Nardi, M.D.
Case Review
MS Teams Molecular

3:30–4:00
4:00–4:30

John Iafrate, M.D., Ph.D.
Lung Cancer Update
MS Teams Molecular

4:30–5:00

All: residents, fellows, HMS students

Retrieved from "https://learn.mghpathology.org/index.php?title=rotation:molecualr-april2020week2&oldid=32128"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital